--- title: 'Senior Director/Head, Field Market Access at Orca Bio' canonical: 'https://feeny.ai/job/senior-director-head-field-market-access-orca-bio-remote-4yx0h3k26zt1' type: 'job' last_seen: '2026-10-16' --- # Senior Director/Head, Field Market Access at Orca Bio - **Company:** Orca Bio - **Location:** Remote - **Compensation:** $270k–$300k - **Employment:** full-time - **Work type:** remote - **Posted:** 2026-09-18 - **Last confirmed live:** 2026-10-16 - **Apply:** https://jobs.lever.co/orcabiosystems/464b469b-ab84-45c5-9e76-772699e0d595 ## Job description More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a commercial-stage biotechnology company redefining the transplant process by developing next-generation cell therapies with the goal of providing significantly better survival rates with dramatically fewer risks. With our purified, high-precision cell therapies we hope to not only replace patients' blood and immune systems with healthy ones, but also restore their lives. Position Summary: the Senior Director, Field Market Access will report to the Head of Market Access and lead our high-performing team of U.S. Payer Account Directors. This team is responsible for expanding patient access, removing reimbursement barriers, and supporting TREGZI’s revenue and profitability goals. This leader will provide strategic direction to maximize TREGZI’s access and value across payer and customer segments. The role will oversee field market access execution, payer strategy, the product value proposition, and tactical planning to support continued commercialization and lifecycle management. The Senior Director will also establish performance metrics and lead internal and external access and disease-education strategies. ## Responsibilities - Lead the U.S. Payer Account Director team, establishing clear priorities, performance expectations, and account engagement strategies. - Ensure market access insights and perspectives are integrated into brand strategy, commercialization plans, and lifecycle management objectives. - Evaluate healthcare market trends that may affect product access, reimbursement, pricing, and contracting strategy. - Direct and execute pricing and access strategies for TREGZI and potential future indications, including reimbursement analysis and, when appropriate, contracting and discount strategies. - Develop pre- and post-launch market engagement strategies that effectively communicate the brand’s value proposition and support patient access. - Lead market access analytics and evaluate team and business performance against defined KPIs. - Partner with Medical Affairs and other stakeholders to anticipate evolving payer evidence requirements and develop long-range evidence strategies. - Recruit, develop, and retain a high-performing team while fostering a results-driven, customer-focused, and collaborative culture. - Develop and manage operating budgets consistent with corporate financial objectives. - Ensure compliance with corporate policies and procedures and all applicable U.S. healthcare laws and regulations. ## Qualifications - Bachelor’s degree required; MBA or other advanced degree preferred. - 10+ years of relevant market access experience, including experience leading high-performing payer or field market access teams. - Comprehensive knowledge of the U.S. healthcare system, payer landscape, reimbursement environment, and related access challenges and opportunities. - Deep functional expertise in market access, pricing and contracting, lifecycle management, and the integration of patient access and support services. - Strong financial and analytical capabilities. - Demonstrated success developing scalable, customer-focused market access strategies. - Strong understanding of the commercialization process, reimbursement integration points, and clinical development. - Commercial experience across areas such as marketing, sales, product launches, pricing, or contracting. - Prior cell therapy or stem cell transplant experience. - Ability to travel as required. The anticipated annual salary range (listed above) for this job is based on prior experience in the role/industry, education, location, internal equity, and other job-related factors as permitted by law. For remote-based positions, this range may vary based on your local market. Full-time employment positions will also be eligible to receive pre-IPO equity and annual bonus, in addition to competitive medical, dental, and vision benefits, PTO, 401(k) plan, life and accidental death and disability coverage, and parental leave benefits. Other perks include subsidized daily lunches and snacks at our on-site locations. ## Who we are We are driven by a passion for science and compassion for patients. We act with urgency to ensure our treatments are one day accessible to all who need them. We live by our core values of passion, courage, and integrity. Excellence in our work means the chance to unlock a better quality of life for our patients, and with that comes tremendous responsibility. We innovate on a path that hasn’t been paved. We embrace an entrepreneurial spirit and take calculated risks to achieve our mission. We aren’t afraid to ask “why not” and challenge the status quo. We maintain a start-up culture of camaraderie and leadership by example, regardless of title. We’re proud to be an equal opportunity employer, and recognize that celebrating our differences creates stronger, lasting solutions that better serve our team, our patients and their healthcare providers. Notice to staffing firms Orca Bio does not accept resumes from staffing agencies with which we do not have a written agreement and specific engagement for a particular opening. Our employment activities, inquiries and offers are managed through our HR/Talent team, and all candidates are presented through this channel only. We do not accept unsolicited resumes, and we rarely outsource recruitment. ## About Orca Bio ## Company Overview - **One-liner**: Orca Bio is a clinical-stage biotechnology company developing high-precision cell therapies to cure blood cancer, genetic blood disorders, and autoimmune diseases without the severe side effects of traditional transplants. - **Entity Type**: Private (Late-Stage Biotech) - **Headquarters**: Menlo Park, California, USA - **Founded**: 2016 - **Founders**: Not publicly available (leadership team has delivered on mission since founding) ## Core Business - **Primary Industry**: Biotechnology / Cell Therapy / Pharmaceutical Manufacturing - **Target Customers**: B2B — healthcare providers, transplant centers, and oncology clinics; ultimately serving patients with hematologic malignancies, genetic blood disorders, and autoimmune diseases - **Mission Statement**: "To deliver a cure without compromise for patients through high precision cell therapies" [orcabio.com](https://orcabio.com/join-our-team/) ## Products & Services - **Orca-T (Lead Therapy)**: Allogeneic T-cell immunotherapy designed to treat hematologic malignancies (AML, ALL, MDS, MPAL). It is a high-precision cell therapy that isolates the less than 1% of cells that provide therapeutic benefit from a standard transplant, aiming to improve survival rates while reducing risks of chronic GvHD. Received **Regenerative Medicine Advanced Therapy (RMAT)** designation and **Orphan Drug Designation** from the FDA. BLA accepted under **Priority Review** in October 2025, with a PDUFA target action date of **April 6, 2026** [siliconvalleyinvestclub.com](https://siliconvalleyinvestclub.com/companies/orca-bio/). - **Orca-Q**: Designed to treat acute leukemias for patients without a fully matched donor. - **OrcaSort Platform (Enabling Technology)**: Proprietary single-cell sorting and purification technology that isolates specific immune and stem cell populations at high precision and scale — the foundation enabling all Orca Bio’s therapies. - **Other Pipeline Therapies**: Intended to treat a broad array of non-malignant blood and immune system disorders. ## Market Standing - **Valuation**: Not publicly disclosed (privately held) - **Total Funding**: **$542M** across 7 rounds (Seed, Series D, Series F, and others) [search results] - **Key Funding Events**: - **Series F (Jan 2026)**: **$250M** led by **Lightspeed Venture Partners** [siliconvalleyinvestclub.com](https://siliconvalleyinvestclub.com/companies/orca-bio/) - **Series D (Jun 2020)**: **$192M** led by **Lightspeed Venture Partners** (11 investors total) - **Annual Revenue**: **$13.5M** (estimated) - **Notable Investors/Partners**: Lightspeed Venture Partners; clinical trial partners include City of Hope, Stanford Health Care, UC Davis, Oregon Health & Sciences University, University of Texas MD Anderson Cancer Center, Sarah Cannon Research Institute [orcabio.com](https://orcabio.com/wp-content/uploads/2022/03/orcabio-corporate-factsheet.pdf) - **Growth Signals**: - Headcount grew **72.3% YoY** to **283 employees** [search results] - Phase 3 primary endpoint met (Feb 2025) - BLA under FDA Priority Review with PDUFA date April 6, 2026 — potential FDA approval and commercial launch imminent - 200+ patients treated in clinical trials to date - Ramping up manufacturing operations with multiple new hires across manufacturing, quality, and operations ## Competitive Advantages - **Precision Cell Sorting Platform**: Orca Bio’s proprietary technology sorts the more than 100 billion cells in a standard allogeneic transplant down to the less than 1% that actually provide therapeutic benefits, creating a high-precision proprietary mixture of immune and stem cells to build a designer immune system for patients. - **Reduced Side Effects**: Designed to control serious complications like chronic GvHD while enabling a potent anti-cancer effect — a significant improvement over traditional transplants. - **Manufacturing Speed**: Consistently achieved donor-to-patient vein-to-vein turnaround times of less than 72 hours across ongoing clinical trials. - **Regulatory Momentum**: RMAT designation and FDA Priority Review for lead therapy Orca-T signal strong regulatory alignment and potential for accelerated path to market. ## Strategic Focus - **Commercialization Readiness**: With a $250M Series F raised in Dec 2025/Jan 2026 and a PDUFA date in April 2026, the company is aggressively scaling manufacturing, quality, and commercial operations to prepare for a potential product launch. - **Manufacturing Scale-Up**: Significant hiring across manufacturing, MSAT, packaging, and cold chain handling roles in Sacramento and Menlo Park. - **Pipeline Expansion**: Advancing Orca-Q for patients without fully matched donors and expanding into broader non-malignant blood and immune system disorders. - **Building the Commercial Organization**: Recent hires include a Chief Commercial Officer (Mike Hirschmann) and Associate Director of Market Development (Mid-West), signaling preparation for a U.S. commercial launch. ## Why Work Here - **Mission-Driven Impact**: "Deliver the promise of a cure, without compromise" — employees work directly on therapies that could transform the lives of patients with blood cancer and serious immune disorders [orcabio.com](https://orcabio.com/join-our-team/) - **Start-Up Culture with Late-Stage Resources**: Described as maintaining a "start-up culture of camaraderie" while being well-funded ($542M total) and approaching a major regulatory milestone [orcabio.com](https://orcabio.com/join-our-team/) - **Rapid Growth & Career Opportunity**: Headcount grew 72% YoY; 36 active job postings at time of research across manufacturing, quality, analytical development, and commercial roles - **Work Environment**: On-site roles in Menlo Park, CA (HQ) and Sacramento, CA (manufacturing facility). Roles span day, night, and 2nd/3rd shifts for manufacturing positions. - **Culture Ratings**: 3.7/5.0 overall on employer review sites (Culture: 3.9, Career: 3.7, Compensation: 3.4, Work-Life: 3.1) - **Top Talent Sources**: Employees come from Genentech, UC Davis, Stanford, BioMarin, Cepheid, Omeros — strong biotech pedigree - **Notable Perks**: Opportunity to work at the cutting edge of cell therapy with a platform that has real potential to change standard of care in transplant medicine ## Sources 1. [orcabio.com - Official Website](https://orcabio.com/join-our-team/) 2. [orcabio.com - Corporate Factsheet](https://orcabio.com/wp-content/uploads/2022/03/orcabio-corporate-factsheet.pdf) 3. [jobs.lever.co/orcabiosystems - Careers Page](https://jobs.lever.co/orcabiosystems) 4. [siliconvalleyinvestclub.com - Orca Bio Profile](https://siliconvalleyinvestclub.com/companies/orca-bio/) 5. [linkedin.com/company/orcabio - LinkedIn](https://linkedin.com/company/orcabio) ## Other roles at Orca Bio - [Associate Director, Orca Account Management - Midwest (IA, IL, IN)](https://feeny.ai/job/associate-director-orca-account-management-midwest-ia-il-in-orca-bio-illinois-hw4tnvwb2brt) — Illinois - [Material Planner](https://feeny.ai/job/material-planner-orca-bio-sacramento-tmfkt0ga77ne) — Sacramento, CA - [Manager, Warehouse](https://feeny.ai/job/manager-warehouse-orca-bio-sacramento-awqj1stjk08h) — Sacramento, CA - [Manager / Senior Manager, Business Systems](https://feeny.ai/job/manager-senior-manager-business-systems-orca-bio-sacramento-9kkyjptn9asw) — Sacramento, CA - [Medical Director / Senior Medical Director, Clinical Development](https://feeny.ai/job/medical-director-senior-medical-director-clinical-development-orca-bio-menlo-whhrnkz37zh5) — Menlo Park, CA - [Senior / Principal Scientist, CMC Analytical Development](https://feeny.ai/job/senior-principal-scientist-cmc-analytical-development-orca-bio-sacramento-11apfdw6byw1) — Sacramento, CA - [Manager, Quality – Commercial Site Onboarding (East Coast)](https://feeny.ai/job/manager-quality-commercial-site-onboarding-east-coast-orca-bio-remote-1a3rz045kad9) - [Director, Medical Information](https://feeny.ai/job/director-medical-information-orca-bio-menlo-park-yen9at2h6zrd) — Menlo Park, CA - [National Senior Director, Field Medical Affairs](https://feeny.ai/job/national-senior-director-field-medical-affairs-orca-bio-menlo-park-gqqfr6jj7egy) — Menlo Park, CA - [Coordinator, Commercial Marketing and MLR](https://feeny.ai/job/coordinator-commercial-marketing-and-mlr-orca-bio-remote-jec414fh179h)